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Abstract Active smoking is a well-established risk factor
for myocardial infarction, but less is known about the
impact of passive smoking, and possible sex differences in
risk related to passive smoking. We investigated active and
passive smoking as risk factors for myocardial infarction in
an 11-year follow-up of 11,762 men and 13,206 women
included in the Tromsø Study. There were a total of 769
and 453 incident cases of myocardial infarction in men and
women, respectively. We found linear age-adjusted rela-
tionships between both active and passive smoking and
myocardial infarction incidence in both sexes. The rela-
tionships seem to be stronger for women than for men.
Age-adjusted analyses indicated a stronger relationship
with passive smoking in ever-smokers than in never-
smokers. After adjustment for important confounders
(body mass index, blood pressure, total cholesterol, HDL
cholesterol and physical activity) the associations with
active and passive smoking were still statistically signifi-
cant. Adjusting for active smoking when assessing the
effect of passive smoking and vice versa, indicated that the
effect of passive smoking in men may be explained by their
own active smoking. In women, living with a smoker
C30 years after the age of 20 increased the myocardial
infarction risk by 40 %, even after adjusting for active
smoking. Passive smoking is a risk factor for myocardial
infarction on its own, but whereas the effect for men seems
to be explained by their own active smoking, the effect in
females remains statistically significant.
Keywords Cigarette smoking  Involuntary smoking 
Passive smoking  Sex  Myocardial infarction
Introduction
Smoking is the most important preventable risk factor for
disease and premature death. Even though the smoking
prevalence in Norway has nearly been halved during the
last 15 years, 17 % of Norwegian men and women aged
16–74 were daily smokers in 2011 [1] and the prevalence
does not differ much between men and women. The risks
of smoking in relation to myocardial infarction (MI) are
well-known [2], but several studies have found that the
impact of smoking is larger in women than in men. A
recently published large meta-analysis of prospective
cohort studies [3] found that female smokers had 25 %
higher adjusted risk of coronary heart disease than men
who smoke. The higher risk of women compared to men
may for different reasons be underestimated [3], and a
previous study from Norway indicated an approximately
adjusted 75 % higher risk in female than in male smokers
[4].
Passive smoking (second hand tobacco smoke), has been
shown to increase the risk of coronary heart disease [5–8].
One prospective study with objective measurement of
exposure found no relationship, however, but living with a
smoker was associated with a two-fold increased myocar-
dial infarction risk in non-smoking participants [9].
There has, however, been little research on whether the
observed sex difference in risk related to active smoking
also applies for passive smoking. A meta-analysis from
1999 indicated no difference between the genders [6]. A
recent case–control study from Costa Rica showed that the
risk of myocardial infarction increased by 23 % in subjects
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living with a smoker and the strength of the relationship did
not differ much between the genders [8]. Thus, the aim of
this population-based prospective study was to elucidate
active and passive smoking as risk factors for myocardial
infarction with emphasis on possible sex differences.
Methods
The Tromsø Study
The Tromsø Study is a population-based prospective study
established in 1974. There have been a total of six surveys
in the Tromsø Study, the last in 2007–2008. The present
study is based on data from the Tromsø 4 survey. This is
the largest survey conducted as a part of the Tromsø Study
and took place during 1994–1995. All residents in the
municipality of Tromsø born before 1970 (i.e. aged 25 and
above) were invited to participate and 27,158 (77 %)
attended [10]. The participants received a questionnaire
along with the invitation and were asked to bring the
completed form when they came for the physical exami-
nation. The questionnaire included questions concerning,
among other topics, active and passive smoking as well as
physical activity.
Measurements and questionnaires
Height and weight measurements were performed in light
clothing. The participant was taken into a separate room
with only one nurse present to measure the blood pressure.
The blood pressure was measured three times after the
participant had been seated for 2 min using an automatic
device (Dinamap Vital Signs Monitor 1846; Criticon, Inc,
Tampa, FL). The mean of the two last measurements was
used in the present analyses.
To obtain the blood sample a venipuncture was per-
formed while the person was seated. The blood test
included measurement of serum total cholesterol and HDL
cholesterol. Analysis of serum total cholesterol was done
by enzymatic colorimetric methods with commercial
kits (CHOD-PAP; Boehringer-Manheim, Mannheim,
Germany). Serum high-density lipoprotein (HDL) was
measured after precipitation of lower density lipoproteins
with manganese chloride. All the analyses were performed
by the Department of Clinical Chemistry, University
Hospital of North Norway.
Subjects were defined as physically inactive if they
reported never participating in hard leisure activities that
would make them sweat or be out of breath, in addition to
being lightly active less than 1 h per week. The participants
were defined as physically moderate active if they reported
light leisure activity for more than 1 h per week, and some,
although less than 1 h per week, hard leisure activity.
Participants reporting hard leisure activity for more than
1 h per week were considered physically active.
Information about history of active smoking was based
on several questions in the questionnaire. With regard to
active smoking, the subjects were categorized into seven
different categories: Never smokers, ex-smokers who quit
C20 years ago, who quit 10–19 years ago, who quit less
than 10 years ago, current smoker who smokes less than 10
cigarettes per day, who smoke 10–19 cigarettes per day and
who currently smoke C20 cigarettes per day.
There were two questions concerning passive smoking
and we assessed passive smoking as two different vari-
ables. The first was based on a question in the questionnaire
asking for how many years the participants had been living
with a daily smoker after their 20th birthday. Their expo-
sure to passive smoking at home was then categorized in
five different groups: Never exposed, exposed less than
10 years, exposed 10–19 years, exposed 20–29 years and
exposed for more than 30 years. The second variable was
related to how many hours per day the respondent was
present in smoke-filled rooms. They answered by giving an
estimate in hours, in our analyses categorized into three
groups (0, 1–6 and [6 h per day). The two indicators of
exposure to cigarette smoke were statistically significantly
(p \ 0.001), but not highly, correlated (Spearman correla-
tion = 0.31 and 0.26 in men and women, respectively).
Identification of myocardial infarction cases
and follow-up
Hospitalized cases of incident MI were identified by link-
ing the Tromsø Study participant list to the discharge
diagnosis register at the University Hospital of North
Norway as described elsewhere [11]. This hospital is the
only hospital in the area. To identify all possible first-ever
MI cases, our search strategy included the following
diagnostic codes: from 1980 to 1998 ICD 9 codes 410-414
and 798-7998; and thereafter ICD 10 codes I20-I25, and
R96 and R98-99. The hospital medical record was then
retrieved for case validation. Discharge letters from hos-
pitalizations in other hospitals were also collected when
appropriate. Further, the Tromsø Study participant list was
linked with the nationwide Causes of Death Registry at
Statistics Norway and the death certificates were retrieved
for those with an underlying or contributing diagnosis of
CVD or sudden unexpected death. Relevant information
was collected from additional sources such as autopsy
reports and records from nursing homes, ambulance ser-
vices and general practitioners. This procedure identified
fatal incident cases of MI that occurred as out-of-hospital
deaths, including deaths that occurred outside Tromsø.
Cases meeting diagnostic criteria for definite or probable
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fatal or non-fatal first-ever MI were classified as MI. WHO
MONICA/MORGAM criteria were used in the algorithms
and included clinical symptoms and signs, findings in
electrocardiograms, values of cardiac biomarkers and
(when applicable) autopsy reports. Silent MIs as defined by
ECG only were not included as cases because of difficulties
in determining the exact date of the event. In the present
analyses, we included MI endpoints till the end of 2005.
Analytical sample
A total of 26,957 persons attended the Tromsø 4 survey and
gave informed consent. Data from 24,968 men and women
were included in the present analyses. Subjects excluded
had experienced a myocardial infarction prior to the
physical examination (n = 684) or had missing values
regarding information about active and passive smoking,
physical activity or the physical examination (n = 1,305).
Statistical analysis
Cox regression was performed to analyze active and pas-
sive smoking as risk factors for myocardial infarction
during follow-up. First we only adjusted for age at start of
follow-up, then we adjusted in concert for age, mean sys-
tolic blood pressure, total serum cholesterol, serum HDL,
body mass index (BMI, kg/m2) and physical activity and
finally, for active smoking (for passive smoking) and pas-
sive smoking (for active smoking). The analysis was per-
formed separately for men and women. Stratified analyses
were performed in order to investigate whether the risk
from passive smoking differed between ever-smokers and
never smokers.
The study follow-up started the day the participant were
clinically examined and lasted till the day they had their
first myocardial infarction, died, emigrated or till the end of
follow-up (end of 2005), whichever came first.
Ninety-five percent confidence intervals were calcu-
lated. Two-sided p values \0.05 were considered statisti-
cally significant. All analyses were performed using SPSS
16.0 software (SPSS Inc. Chicago, Illinois, USA).
Results
Characteristics of cases of incident MI
During follow-up, 3.4 % of the females and 6.5 % of the
males had an incident myocardial infarction. There were a
total of 1,222 cases of myocardial infarction, 769 cases in
men and 453 in women. Age at start of follow-up was
higher (68.0 years) in female cases of myocardial infarc-
tion than in male cases (60.7 years). Age at enrollment in
subjects who did not have a myocardial infarction during
follow-up was, as expected, considerably lower than in
subjects who had a myocardial infarction during follow-up
and did not differ much between women (45.8 years) and
men (44.7 years). The unadjusted baseline characteristics
are presented in Table 1. Gender specific analyses indi-
cated no statistically significant (p C 0.6) linear relation-
ships between time spent in smoke-filled rooms and
myocardial infarction incidence. In women, no significant
relationship was found for active smoking (p = 0.12).
Subjects who suffered a myocardial infarction during
follow-up had higher body mass index, blood pressure and
total cholesterol and lower HDL cholesterol and less
physical activity than subjects who did not have a myo-
cardial infarction. All of these differences were statistically
significant (p B 0.002).
Active and passive smoking
Overall, we found that 36 % of the women and 38 % of the
men were current smokers (data not shown). Men did,
however, smoke more than did the females. Whereas 1,227
(10.4 %) of the 11,762 males smoked more than 20 ciga-
rettes per day, only 565 (4.3 %) of the 13,206 females did
so (Table 2). There was not much difference between men
and women with regard to for how long time they had been
living with a smoker; approximately 15 % reported to have
lived with a smoker for more than 30 years. Men reported
more often than women to spend much time in smoke-filled
rooms (Table 2).
Table 2 shows active and passive smoking as risk fac-
tors for myocardial infarction. Age-adjusted analyses (first
column of hazard ratios) demonstrate that the risk of
myocardial infarction increased linearly for both active and
passive smoking in both sexes, but rather consistently
stronger for women than for men. Formal test for interac-
tion by sex for the three variables were not statistically
significant or only borderline significant, however. After
adjustments for important confounders (body mass index,
blood pressure, total cholesterol, HDL cholesterol and
physical activity), the effects of active and passive smoking
were still statistically significant (second column).
Adjusting for active smoking when assessing the effect of
passive smoking and vice versa (third column) indicated
that the effect of passive smoking in men can be explained
by their own active smoking, while in women the effect of
passive smoking, operationalized by the number of years
living with a smoker, still was statistically significantly
associated with myocardial infarction incidence and indi-
cated a 40 % increased risk of myocardial infarction in
women who had lived with a smoker for C30 years. A
formal test indicated a marginally statistically significant
(p = 0.03) interaction by sex when all three interactions
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terms for the smoking variables were included in the model
as a block. In a fully adjusted model (third column for each
sex in Table 2) including in addition one interaction term
(for ‘‘Own smoking habits’’, ‘‘Living with a smoker’’, or
‘‘Time spent in smoke filled rooms’’) at the time demon-
strated a significant interaction with sex for the two first
variables (p = 0.02 and 0.04, respectively) and no signif-
icant interaction (p = 0.14) for the last variable.
Passive smoking and incident MI in never and ever
smokers
Passive smoking was a risk factor for myocardial infarction
in never smoking women (Table 3). Both age-adjusted and
adjusted for the other confounders there was in women a
positive dose–response association between living with a
smoker and the risk of myocardial infarction in females
with a 60 % (95 % CI 10–120) increased risk in women
living with a smoker for more than 29 years compared with
a female who never had been living with smoker after the
age of 20. There was no effect of living with a smoker in
men and no effect of time spent in a smoke-filled room in
neither of the sexes.
Similarly, Table 4 shows passive smoking as a predictor
for myocardial infarction in ever smoking subjects (current
or previous smokers). In analyses only adjusted for age, we
found an association for both variables conveying infor-
mation about passive smoking and myocardial infarction
Table 1 Baseline characteristics in men and women, according to myocardial infarction (MI) during follow-up. The Tromsø Study 1994–1995
Men (n = 11,762) Women (n = 13,206)
No MI (N = 10,993) MI (N = 769) No MI (N = 12,753) MI (N = 453)
Age 44.7 (13.5) 60.7 (12.8) 45.8 (14.8) 68.0 (11.7)
BMI (kg/m2) 25.5 (3.3) 26.6 (3.6) 24.7 (4.2) 26.8 (4.8)
Serum lipids (mmol/l)
Total cholesterol 5.96 (1.20) 6.82 (1.17) 5.97 (1.36) 7.28 (1.35)
HDL 1.35 (0.35) 1.31 (0.35) 1.65 (0.40) 1.58 (0.44)
Blood pressure (mm Hg)
Systolic 136.3 (16.4) 149.4 (21.6) 130.8 (21.5) 161.6 (26.5)
Diastolic 79.4 (11.5) 86.9 (13.2) 75.8 (12.3) 88.5 (15.5)
Physical activity (%)
Inactive 16.7 24.2 19.2 39.3
Moderate 44.1 51.0 55.8 51.2
Active 39.2 24.8 25.0 9.5
Smoking habits (%)
Never-smoker 32.3 15.0 39.8 46.6
Stopped C20 years ago 9.0 19.6 5.1 5.7
Stopped 10–19 years ago 7.9 10.9 7.1 3.5
Stopped \10 years ago 13.4 12.1 12.1 5.5
Current \10 cigarettes/day 7.6 8.8 11.7 15.5
Current 10–19 cigarettes/day 19.5 21.2 20.0 18.3
Current C20 cigarettes/day 10.3 12.4 4.3 4.9
Living with a smokera (%)
Never 33.3 24.7 30.8 17.0
\10 years 21.4 7.3 20.6 3.3
10–19 years 18.3 13.3 19.1 10.4
20–29 years 13.9 18.6 14.1 17.2
C30 years 13.0 36.2 15.4 52.1
Time spent in smoke-filled rooms (%)
0 h/day 41.7 48.9 55.9 59.4
1–6 h/day 39.8 27.2 29.5 23.2
[6 h/day 18.4 23.9 14.6 17.4
Values are mean (standard deviations in parentheses) or percentages
a If a person currently is or has been living with a smoker since his/her 20th birthday
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risk in both sexes (albeit the relationship seems stronger in
women). The effect of living with a smoker was attenuated
when adjusting for the other cardiovascular risk factors, but
it was still statistically significant. When adjusting for their
own active smoking and the time spent in smoke filled
rooms in addition, the effect of living with a smoker was
still significant in women (HR = 1.3 for C30 years; 95 %
CI 0.9–2.0; p value for linear trend = 0.04).
Stronger relationships in younger subjects
Age-stratified analyses suggest a stronger impact of both
active and passive smoking in the relatively young compared
to older subjects. A formal test indicated a statistically sig-
nificant (p = 0.004 and 0.03 in men and women, respec-
tively) linear interaction with age when all three interaction
terms for the smoking variables were included in the model
as a block. In a fully adjusted model (third column for each
sex in Table 2) including in addition one interaction term
(for ‘‘Own smoking habits’’, ‘‘Living with a smoker’’, or
‘‘Time spent in smoke filled rooms’’) at the time demon-
strated a significant interaction with age for all three vari-
ables for men (p B 0.004) and for ‘‘Living with a smoker’’ in
women (p = 0.004). The effects of smoking were strongest
for ‘‘Own smoking habits’’ and in women. Younger and
middle-aged females, aged 25–54 at enrollment (69 cases of
myocardial infarction), who currently smoked C20 ciga-
rettes per day had a higher risk of myocardial infarction
(HR = 3.8; 95 % CI 1.4–9.9) than females aged 55-69
(HR = 2.2; 95 % CI 1.0–4.9) and females aged C70 years
(HR = 1.6; 95 % CI 0.4–6.9). The same analysis for men
showed lower estimates; HR = 2.7 (95 % CI 1.7–4.3) in
men aged 25–54 at enrollment, HR = 1.1 (95 % CI 0.7–1.9)
in men aged 55–69 and HR = 1.0 (95 % CI 0.3–3.0) in men
aged C70 years at enrollment. One should note the wide
confidence intervals, however.
Table 2 Active and passive smoking as risk factors for myocardial infarction (MI) in men and women, The Tromsø Study, 1994–2005














Never-smoker 3,668 115 1 (–) 1 (–) 1 (–) 5,285 211 1 (–) 1 (–) 1 (–)
Stopped C20 years ago 1,141 151 1.3 (1.0–1.6) 1.2 (1.0–1.6) 1.2 (0.9–1.5) 672 26 0.8 (0.5–1.1) 0.8 (0.5–1.2) 0.8 (0.5–1.2)
Stopped 10–19 years ago 947 84 1.5 (1.1–2.0) 1.3 (1.0–1.8) 1.3 (0.9–1.7) 919 16 0.8 (0.5–1.3) 0.9 (0.5–1.4) 0.8 (0.5–1.4)
Stopped \10 years ago 1,569 93 1.4 (1.1–1.9) 1.3 (1.0–1.7) 1.2 (0.9–1.6) 1,572 25 1.2 (0.8–1.9) 1.3 (0.9–2.0) 1.2 (0.8–1.8)
Current \10 cigarettes/day 898 68 1.5 (1.1–2.1) 1.6 (1.2–2.2) 1.5 (1.1–2.0) 1,560 70 2.3 (1.8–3.1) 2.6 (1.9–3.4) 2.2 (1.6–3.0)
Current 10–19 cigarettes/day 2,312 163 1.9 (1.5–2.4) 1.8 (1.4–2.3) 1.7 (1.3–2.2) 2,633 83 2.5 (1.9–3.2) 2.7 (2.0–3.5) 2.2 (1.6–3.1)
Current C20 cigarettes/day 1,227 95 2.5 (1.9–3.3) 2.2 (1.7–2.9) 1.9 (1.4–2.6) 565 22 3.5 (2.2–5.6) 3.6 (2.3–5.7) 3.1 (1.8–5.1)
p value linear trend \0.001 \0.001 \0.001 \0.001 \0.001 \0.001
Living with a smokerf
Never 3,853 190 1 (–) 1 (–) 1 (–) 4,011 77 1 (–) 1 (–) 1 (–)
\10 years 2,412 56 0.8 (0.6–1.1) 0.9 (0.7–1.2) 0.8 (0.6–1.1) 2,643 15 0.6 (0.4–1.1) 0.7 (0.4–1.2) 0.7 (0.4–1.2)
10–19 years 2,119 102 1.2 (1.0–1.6) 1.2 (0.9–1.5) 1.1 (0.8–1.4) 2,477 47 1.2 (0.8–1.7) 1.3 (0.9–1.8) 1.2 (0.8–1.7)
20–29 years 1,674 143 1.5 (1.2–1.9) 1.4 (1.1–1.7) 1.2 (1.0–1.5) 1,872 78 1.5 (1.1–2.1) 1.5 (1.1–2.1) 1.3 (1.0–1.9)
C30 years 1,704 278 1.5 (1.2–1.8) 1.3 (1.1–1.6) 1.1 (0.9–1.4) 2,203 236 1.8 (1.4–2.3) 1.8 (1.4–2.3) 1.4 (1.1–1.9)
p value linear trend \0.001 \ 0.001 0.145 \0.001 \0.001 0.004
Time spent in smoke-filled rooms
0 h/day 4,965 376 1 (–) 1 (–) 1 (–) 7,392 269 1 (–) 1 (–) 1 (–)
1–6 h/day 4,589 209 1.1 (0.9–1.3) 1.1 (1.0–1.4) 1.0 (0.8–1.2) 3,873 105 1.8 (1.5–2.3) 1.9 (1.5–2.3) 1.2 (0.9–1.6)
[6 h/day 2,208 184 1.7 (1.4–2.0) 1.6 (1.3–1.9) 1.2 (0.9–1.4) 1,941 79 2.1 (1.6–2.7) 2.0 (1.6–2.7) 1.1 (0.8–1.5)
p value linear trend \0.001 \0.001 0.198 \0.001 \0.001 0.182
a N Number of subjects included in the analyses at baseline
b n Number of cases of myocardial infarction
c Hazard ratios (95 % confidence interval), adjusted for age
d Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity
e Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity as well as passive smoking (for active smoking) or
active smoking (for passive smoking)
f If a person currently is or has been living with a smoker since his/her 20th birthday
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Population attributable risk for passive smoking
Applying the adjusted risk estimates in women who never
had been a smoker, we found that the population attribut-
able risk (PAR) for myocardial infarction for ever been
exposed to passive smoking (i.e., ever lived a smoker since
her 20th birthday) was 19 %, while it was 18 % in all
women (data not shown). As we only found a significant
relationship between passive smoking and myocardial
infarction risk in women, we only report the PAR estimate
for women.
Discussion
The present study confirms that smoking increases the
incidence of myocardial infarction and supports the notion
that the relationships are stronger in women than in men
[2–4]. Furthermore, this prospective cohort study found
that passive smoking, at least in women, was an indepen-
dent risk factor for myocardial infarction. The age-adjusted
relationship in women between years living with a smoker
after the age of 20 and myocardial infarction risk was as
least as strong in ever smokers as in never smokers. In men,
most of the association with passive smoking was probably
explained by confounders, particularly their own active
smoking.
Comparison with previous studies and explanations
for the findings
Previous studies concerning the impact of passive smoking
on myocardial infarction risk have shown that passive
smoking or living with a smoker increases the risk of
myocardial infarction [5–9]. Our results (at least before
adjustments for active smoking were undertaken) are in
accordance with this. Furthermore, we find that the
effect of passive smoking was more pronounced in women.
The latter seems to be in variance with most previous
studies [6, 8, 9].
The findings of the large INTERHART case–control
study indicated that the effect of passive smoking was
weaker in current than in ex- or never smokers [7], but
other studies have not found major differences [5, 8, 9].
We have no obvious explanation for the probably
stronger relationship in women for both active and passive
Table 3 Passive smoking as a risk factor for myocardial infarction (MI) in men and women who have never been actively smoking, The Tromsø
Study, 1994–2005














Never 2,226 68 1 (–) 1 (–) 1 (–) 2,529 49 1 (–) 1 (–) 1 (–)
\ 10 years 759 10 0.7 (0.4–1.4) 0.7 (0.4–1.4) 0.7 (0.4–1.5) 803 8 0.9 (0.4–1.8) 0.9 (0.4–2.0) 1.0 (0.5–2.1)
10–19 years 364 13 1.2 (0.6–2.1) 1.2 (0.6–2.1) 1.2 (0.6–2.1) 583 22 1.4 (0.8–2.3) 1.4 (0.8–2.2) 1.4 (0.8–2.3)
20–29 years 194 8 0.8 (0.4–1.7) 0.7 (0.3–1.5) 0.7 (0.3–1.6) 528 31 1.4 (0.9–2.2) 1.3 (0.8–2.1) 1.3 (0.9–2.1)
C30 years 125 16 1.2 (0.7–2.1) 1.1 (0.6–2.0) 1.1 (0.6–2.1) 842 101 1.4 (1.0–2.0) 1.5 (1.0–2.1) 1.6 (1.1–2.2)
p value linear trend 0.731 0.959 0.885 0.028 0.021 0.009
Time spent in smoke-filled rooms
0 h/day 2,272 86 1 (–) 1 (–) 1 (–) 4,220 189 1 (–) 1 (–) 1 (–)
1–6 h/day 1,231 26 1.1 (0.7–1.7) 1.0 (0.6–1.6) 1.0 (0.6–1.6) 866 15 0.8 (0.5–1.3) 0.7 (0.5–1.3) 0.7 (0.4–1.2)
[6 h/day 165 3 0.7 (0.2–2.3) 0.8 (0.3–2.6) 0.8 (0.3–2.7) 199 7 0.9 (0.4–1.8) 0.8 (0.4–1.7) 0.7 (0.3–1.5)
p value linear trend 0.865 0.785 0.761 0.393 0.348 0.138
a N Number of subjects included in the analyses at baseline
b n Number of cases of myocardial infarction
c Hazard ratios (95 % confidence interval), adjusted for age
d Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity
e Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity as well as living with a smoker
(for smoke-filled room) and smoke-filled room (for living with smoker)
f If a person currently is or has been living with a smoker since his/her 20th birthday
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smoking with regard to the risk of myocardial infarction,
and not much is known about how smoking may have
different impacts in men and women [12]. It is possible
that there is an interaction between some female specific
risk factors (e.g., polycystic ovarian syndrome (PCOS),
the use of oral contraceptives) and smoking. PCOS
affects 5–10 % of women in a general population [13,
14] and is associated with several known risk factors for
myocardial infarction (e.g., obesity, insulin resistance).
The use of oral contraceptives in combination with
smoking increases the risk of myocardial infarction [12],
but this is of marginal relevance in this study as there
were few cases among the females in fertile age. Some
studies have shown an inverse relationship between age
at menopause and myocardial infarction risk [15], and
smoking lowers age at natural menopause by 1–2 years
[16]. This could contribute to the higher myocardial
infarction rate in female smokers. One likely explanation
for the fact that the association of passive smoking with
MI incidence was found predominately in women may
be that men tend to smoke more than women. In current
smokers, 28 and 12 % of men and women, respectively,
smoked 20 cigarettes or more per day. Hence, a woman
living with a male smoker might have a higher exposure
to passive smoking than a man living with a female
smoker.
Our data also support that the impact of smoking (both
active and passive) on the MI incidence is stronger in
younger than in older subjects. This was not unexpected as
the relative risk associated with smoking is higher in rel-
atively young individuals than in older subjects [2].
The INTERHEART study showed that in subjects who
never had smoked cigarettes, passive smoking accounted
for 10.8 and 18.6 % of all myocardial infarctions in women
and men, respectively [7]. Another study indicated that
passive smoking accounted for 9 % of the female cases and
7 % of the male cases [8]. The present study found that the
PAR for passive smoking was 18 % in women, but it is
difficult to compare PAR estimates from previous studies
because of different threshold for being considered exposed
for passive smoking as well as different prevalence of
passive smoking.
Limitations and strengths
Population studies like this one may be prone to selection
bias, as there will be the people who are healthy that are able
to come to the clinical examination and participate in the
Table 4 Passive smoking as a risk factor for myocardial infarction (MI) in men and women who currently are or previously have been actively
smoking, The Tromsø Study, 1994–2005














Never 1,627 122 1 (–) 1 (–) 1 (–) 1,482 28 1 (–) 1 (–) 1 (–)
\10 years 1,653 46 0.8 (0.5–1.1) 0.8 (0.6–1.2) 0.9 (0.6–1.2) 1,840 7 0.4 (0.2–0.9) 0.4 (0.2–1.0) 0.5 (0.2–1.1)
10–19 years 1,755 89 1.1 (0.8–1.4) 1.0 (0.8–1.4) 1.1 (0.8–1.4) 1,894 25 0.9 (0.5–1.6) 1.0 (0.6–1.7) 1.0 (0.6–1.7)
20–29 years 1,480 135 1.4 (1.1–1.8) 1.3 (1.0–1.6) 1.3 (1.0–1.6) 1,344 47 1.4 (0.9–2.2) 1.4 (0.9–2.2) 1.3 (0.8–2.1)
C30 years 1,579 262 1.4 (1.1–1.7) 1.2 (1.0–1.5) 1.1 (0.9–1.4) 1,361 135 1.8 (1.2–2.7) 1.7 (1.1–2.6) 1.3 (0.9–2.0)
p value linear trend \0.001 0.01 0.108 \0.001 \0.001 0.044
Time spent in
smoke-filled rooms
0 h/day 2,693 290 1 (–) 1 (–) 1 (–) 3,172 80 1 (–) 1 (–) 1 (–)
1–6 h/day 3,358 183 1.0 (0.8–1.2) 1.1 (0.9–1.4) 1.0 (0.8–1.2) 3,007 90 2.6 (1.9–3.5) 2.5 (1.8–3.4) 1.7 (1.2–2.4)
[6 h/day 2,043 181 1.5 (1.2–1.8) 1.5 (1.2–1.8) 1.2 (0.9–1.5) 1,742 72 2.6 (1.9–3.6) 2.4 (1.7–3.4) 1.4 (1.0–2.1)
p value linear trend \0.001 \0.001 0.132 \0.001 \0.001 0.084
a N Number of subjects included in the analyses at baseline
b n Number of cases of myocardial infarction
c Hazard ratios (95 % confidence interval), adjusted for age
d Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity
e Adjusted for age, mean systolic blood pressure, total serum cholesterol, serum HDL, BMI and physical activity as well as active smoking,
living with a smoker (for smoke-filled room) and smoke-filled room (for living with smoker)
f If a person currently is or has been living with a smoker since his/her 20th birthday
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study. We have previously reported lower mortality in
attendees to the Tromsø 4 survey according to attendance to
previous surveys they were invited to [10] and similar studies
conducted in Norway have demonstrated higher morbidity
and mortality in non-attenders than in subjects who took part
in the surveys [17, 18]. The higher morbidity in non-
attenders does, however, influence our findings only if the
relationship between smoking and myocardial infarction is
different in the large majority (77 %) who chose to attend the
Tromsø 4 survey and in those who did not attend.
Data concerning smoking habits in the study were from
a self-administered questionnaire which may have intro-
duced an information bias. Some previous studies have
used cotinine measurements as an objective measure of
passive smoking [5, 9], only one of them demonstrated an
association between serum cotinine level and myocardial
infarction risk [5]. We have no objective measures of
tobacco exposure like cotinine or thiocyanate. A previous
Norwegian study showed that the relation between self-
reported smoking habits and the measure of serum thio-
cyanate was strong if the question was asked in a neutral
setting [19]. As the questions about active and passive
smoking were included in a self-administered question-
naire, in a neutral setting, we believe that the validity was
good, although we recognize that the tobacco use stated in
this study probably is underreported.
In the present study we used two variables to measure
passive smoking: How long they had been living with a
smoker after their 20th birthday and how many hours per
day they have spent in a smoke-filled room. The two
variables were not highly correlated (Spearman correlation
was approximately 0.3). Thus, the two variables probably
reflect different types of exposure. We found that the
relationships with myocardial infarction were stronger with
years lived with a smoker than with number of hours per
day in smoke-filled rooms. It is possible that the ‘‘smoke-
filled room’’ question is somewhat ambiguous as it may
include smoke filled rooms at workplaces (due to ambient
air pollution) as well as passive smoking at home and at the
workplace. This ambiguity might constitute a possible
information bias, and we believe that it is correct to rather
focus on the ‘‘living with smoker’’ variable which clearly
reflects exposure to cigarette smoking.
Another possible limitation is the fact that the survey
was administered in 1994, and we have no information
regarding changes in smoking habits, both active and
passive smoking, during follow-up. As the smoking prev-
alence in the Norwegian population has been reduced, we
assume that some subjects classified as ‘‘current smokers’’
were ex-smokers by the time they had their infarction.
Thus, our estimates of the risk of myocardial infarction
associated with current smoking are probably underesti-
mated because some in the ‘‘current smokers’’ group truly
were ‘‘ex-smokers’’, hence contributing a lower risk than a
true ‘‘current smoker’’ to the results. Similar effects may
have taken place with regard to exposure to passive
smoking although the information concerning long dura-
tion of living with a smoker has probably not changed
much during follow-up. It is a common finding in pro-
spective studies that the relationship between the exposure
and end-point becomes weaker with increasing duration of
follow-up. This has also been seen in a study of the effect
of passive smoking [5].
The study has, however, also some important strengths.
This population based prospective study included 24,968
participants and the participation rate to the survey was
high (77 %). The analyses are prospective, including
incident cases, which rules out the effect of disease on the
reporting of smoking habits. The analyses include all fatal
and non-fatal cases in the study population, not only the
non-fatal cases as in case–control studies [7, 8]. Out of the
411 men who died during follow-up, 194 (47 %) died
within 2 days of the MI, i.e., most probably due to the MI.
The corresponding figure in women was 50 % (144 of 289
deaths). Thus, nearly 30 % of the cases would have not
been available for interview in a case–control study. Fur-
thermore, we were able to adjust for baseline levels of the
other traditional risk factors for myocardial infarction (total
cholesterol, HDL cholesterol, blood pressure and physical
activity), and we have also adjusted for active smoking
when assessing the effect of passive smoking and vice
versa.
Conclusion
The present study confirmed that smoking is an important
risk factor for myocardial infarction and that smoking also
in this respect is more detrimental for women [3]. The
results for passive smoking give furthermore some support
for a stronger effect in women than men. Passive smoking
is a risk factor for myocardial infarction, but whereas the
effect for men seems to be explained by their own active
smoking, the effect in females remains statistically signif-
icant and approximately 20 % of the incident cases of
myocardial infarction in women in this population can be
attributed to passive smoking. Thus, the public health
impact of our findings is not negligible. More research is,
however, needed into the mechanisms that contribute to
this elevated risk, particularly with regard to the possible
sex differences.
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